title: Antibody fragments for controlled delivery of therapeutic agents.
authors.affiliation: Colworth Laboratories, Sharnbrook, U.K.
authors.forename: M E
authors.initials: ME
authors.lastname: Verhoeyen
authors.forename: C P
authors.initials: CP
authors.lastname: van der Logt
authors.forename: T S
authors.initials: TS
authors.lastname: Beggs
authors.forename: P J
authors.initials: PJ
authors.lastname: Davis
mesh_terms: D000818:Animals; D000907:Antibodies, Bacterial / Q000627:therapeutic use; D018033:Antibodies, Bispecific / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000235:genetics / Q000627:therapeutic use; D016503:Drug Delivery Systems; D005949:Glucose Oxidase / Q000627:therapeutic use; D006801:Humans; D018796:Immunoconjugates / Q000235:genetics / Q000627:therapeutic use*; D007128:Immunoglobulin Fragments / Q000235:genetics / Q000627:therapeutic use*; D015202:Protein Engineering; D013291:Streptococcus / Q000276:immunology
chemical_list: D000907:Antibodies, Bacterial; D018033:Antibodies, Bispecific; D000911:Antibodies, Monoclonal; D018796:Immunoconjugates; D007128:Immunoglobulin Fragments; D005949:Glucose Oxidase